Finally, intranasal insulin increases IR activation, activates the PI3K/AKT/mTOR pathway, reduces IRS1 phosphorylation and enhances ERK1/2 activation in 3xTg-AD mice [248, 249]. Here, INSR is linked to Alzheimer disease.